Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial
Wadden, Thomas A, Bailey, Timothy S, Billings, Liana K, Davies, Melanie, Frias, Juan P, Koroleva, Anna, Lingvay, Ildiko, O’Neil, Patrick M, Rubino, Domenica M, Skovgaard, Dorthe, Wallenstein, Signe O. R, Garvey, W. Timothy
Published in JAMA : the journal of the American Medical Association (13.04.2021)
Published in JAMA : the journal of the American Medical Association (13.04.2021)
Get full text
Journal Article
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial
Pieber, Thomas R, Bode, Bruce, Mertens, Ann, Cho, Young Min, Christiansen, Erik, Hertz, Christin L, Wallenstein, Signe O R, Buse, John B, Akın, S, Aladağ, N, Arif, A A, Aronne, L J, Aronoff, S, Ataoglu, E, Baik, S H, Bays, H, Beckett, P L, Berker, D, Bilz, S, Bode, B, Braun, E W, Buse, J B, Canani, L H S, Cho, Y M, Chung, C H, Colin, I, Condit, J, Cooper, J, Delgado, B, Eagerton, D C, El Ebrashy, I N, El Hefnawy, M H M F, Eliaschewitz, F G, Finneran, M P, Fischli, S, Fließer-Görzer, E, Geohas, J, Godbole, N A, Golay, A, Gorban de Lapertosa, S, Gross, J L, Gulseth, H L, Helland, F, Høivik, H O, Issa, C, Kang, E S, Keller, C, Khalil, S H A, Kim, N H, Kim, I J, Klaff, L J, Laimer, M, LaRocque, J C, Lederman, S N, Lee, K-W, Litchfield, W R, Manning, M B, Mertens, A, Morawski, E J, Murray, A V, Nicol, P R, O'Connor, T M, Oğuz, A, Ong, S, Özdemir, A, Palace, E M, Palchick, B A, Pereles-Ortiz, J, Pieber, T, Prager, R, Preumont, V, Riffer, E, Rista, L, Rudofsky, G, Sarı, R, Scheen, A, Schultes, B, Seo, J A, Shelbaya, S A, Sivalingam, K, Sorli, C H, Stäuble, S, Streja, D A, T'Sjoen, G, Tetiker, T, Van Gaal, L, Vercammen, C, Warren, M L, Weinstein, D L, Weiss, D, White, A, Winnie, M, Wium, C, Yavuz, D
Published in The lancet. Diabetes & endocrinology (01.07.2019)
Published in The lancet. Diabetes & endocrinology (01.07.2019)
Get full text
Journal Article
Clinically-Relevant Weight Loss is Achieved Independently of Early Weight Loss Response to Once-Weekly Subcutaneous Semaglutide 2.4 MG (STEP 4)
Mosenzon, Ofri, Garvey, W Timothy, Hesse, Dan, Koroleva, Anna, Kushner, Robert F, Lim, Soo, Lingvay, Ildiko, Wallenstein, Signe O R, Wadden, Thomas A, Le Roux, Carel W
Published in Journal of the Endocrine Society (03.05.2021)
Published in Journal of the Endocrine Society (03.05.2021)
Get full text
Journal Article
Once-weekly Subcutaneous Semaglutide 2.4 mg Reduces Body Weight in Adults with Overweight or Obesity Regardless of Baseline Characteristics (STEP 1)
Kushner, Robert F, Garvey, W Timothy, Hesse, Dan, Koroleva, Anna, Lim, Soo, Lingvay, Ildiko, Mosenzon, Ofri, Wallenstein, Signe O R, Wadden, Thomas A, le Roux, Carel W
Published in Journal of the Endocrine Society (03.05.2021)
Published in Journal of the Endocrine Society (03.05.2021)
Get full text
Journal Article
Abstract 9: Once-weekly subcutaneous semaglutide 2.4 mg reduces body weight in adults with overweight or obesity regardless of baseline characteristics (STEP 1)
Suresh, Swaroop H, Kushner, Robert F, Garvey, W Timothy, Hesse, Dan, Koroleva, Anna, Lim, Soo, Lingway, Ildiko, Wallenstein, Ofri Mosenzon Signe O R, Wadden, Thomas A, Roux, Carel W Le
Published in Indian journal of endocrinology and metabolism (01.03.2022)
Published in Indian journal of endocrinology and metabolism (01.03.2022)
Get full text
Journal Article